The current state of the art in HIV microbicide research is summarized in this web site. It includes an overview of all the key routes by which scientists are trying to develop microbicides, and summarizes the key results from studies reported to date.
Founded in 1998, the Alliance for Microbicide Development is a nonprofit, multidisciplinary, multisectoral organization that employs monitoring, research, communication, convening, and evidence-based advocacy to speed development of microbicides to prevent HIV and other sexually transmitted infections.
CONRAD exists to facilitate the rapid development of safe, acceptable, affordable products and methods that provide contraception and/or prevent the sexual transmission of HIV/AIDS and other infections. Click on Microbicides on the top menu bar for information specific to microbicides.
Eldis is one of a family of knowledge services from the Institute of Development Studies, Sussex, England. Eldis is core funded by Sida, Norad, SDC and DFID. Eldis aims to share the best in development, policy, practice and research.
The Global Campaign for Microbicides is a broad-based, international effort to build support among policy makers, opinion leaders, and the general public for increased investment into microbicides and other user-initiated prevention methods. Through advocacy, policy analysis, and social science research, the Campaign's diverse network of over 300 NGOs works to accelerate product development, facilitate widespread access and use, and protect the needs and interests of users, especially women.
IPM is a nonprofit product development partnership established in 2002 to prevent HIV transmission by accelerating the development and availability of a safe and effective microbicide for use by women in developing countries. IPM is committed to providing women with an affordable and self-initiated HIV-prevention strategy to reduce the cycle. Like the promise of a future AIDS vaccine, microbicides represent an essential component of an integrated and comprehensive global response to the HIV/AIDS epidemic.
This March 5, 2009 article, entitled “AIDS researchers turn attention to microbicides,” reports that in the absence of a vaccine, virus-blocking gels offer renewed hope for preventing the spread of HIV. New studies support the idea, which is especially promising for women.
The MDP is the result of successful grant applications funded by the Medical Research Council and the U.K. Government’s Department for International Development. The MDP is coordinated jointly by the MRC Clinical Trials Unit and Imperial College at St Mary’s Hospital. These two institutions are directly responsible to the MRC and the Department for International Development for the conduct of the program.
The Microbicide Trials Network is a U.S. National Institutes of Health-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV.
This page on this web site provides a large number of links concerning Microbicides & HIV/AIDS.
This web site cites the WHO’s statement on the need and development of microbicides to protect against STDs including HIV. Descriptions of how they work, cost, and research are discussed.